Internal Medicine, Pulmonary Disease · Norwich, CT
NPI
1225326804
Since 2011
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
79 Wawecus St Ste 103
Norwich, CT, 06360
Phone (860) 886-1862
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
1,867 services
Medicare patients, 2024
515
Average age 74
Drug cost, 2024
$2.0M
3,423 prescriptions
Company payments, 2025
$1,753
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Atul V Palkar was code 99214 (office e&m - established), 445 times for 280 patients. In total Atul V Palkar billed 1,867 services in 50 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 445 | 280 | $93.47 | $42K |
| 99291 Critical Care E&M | Facility | 178 | 85 | $174.21 | $31K |
| 99215 Office E&M - Established | Office | 125 | 99 | $145.72 | $18K |
| 99292 Critical Care E&M | Facility | 119 | 55 | $87.14 | $10K |
| 94060 Pulmonary Function Testing | Office | 99 | 94 | $32.22 | $3,190 |
| 94729 Pulmonary Function Testing | Office | 90 | 86 | $44.53 | $4,008 |
| 99232 Hospital E&M - Subsequent | Facility | 83 | 61 | $64.65 | $5,366 |
| 94726 Pulmonary Function Testing | Office | 79 | 77 | $41.92 | $3,312 |
| 99406 Behavioral Health Services | Office | 61 | 30 | $15.31 | $934 |
| 99213 Office E&M - Established | Office | 49 | 42 | $64.76 | $3,173 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 48 | 46 | $13.55 | $650 |
| 99223 Hospital E&M - Initial | Facility | 37 | 37 | $139.47 | $5,160 |
| 76604 Ultrasound - Nonspecific | Office | 37 | 21 | $47.41 | $1,754 |
| 94727 Pulmonary Function Testing | Office | 28 | 28 | $35.23 | $987 |
| 99205 Office E&M - New | Office | 25 | 25 | $165.69 | $4,142 |
By year: 2022 $180K for 1,929 services; 2023 $162K for 1,784 services; 2024 $146K for 1,867 services.
Medicare prescription drug claims, 2024
In 2024, the drug Atul V Palkar prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 540 prescriptions and refills. In total Atul V Palkar wrote 3,423 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 540 | 1,233 | 169 | $793K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 446 | 997 | 203 | $21K |
| Prednisone Generic | 400 | 435 | 234 | $1,200 |
| Azithromycin Generic | 230 | 289 | 142 | $1,232 |
| Montelukast Sodium Generic | 204 | 575 | 69 | $2,150 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 161 | 385 | 56 | $174K |
| Roflumilast Generic | 139 | 289 | 34 | $22K |
| Breo Ellipta Fluticasone/Vilanterol | 115 | 224 | 38 | $89K |
| Azelastine Hcl Generic | 79 | 204 | 31 | $3,418 |
| Ventolin Hfa Albuterol Sulfate | 70 | 138 | 28 | $8,549 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 68 | 156 | 25 | $75K |
| Fluticasone Propionate Generic | 62 | 158 | 33 | $1,026 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 56 | 122 | 19 | $9,786 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 52 | 102 | 16 | $64K |
| Spiriva Respimat Tiotropium Bromide | 48 | 102 | 12 | $51K |
Brand drugs: - claims; generic drugs: 1,717 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Atul V Palkar $1,753 ($1,753 in general payments such as food, travel and fees) from 25 companies. The largest payer was GlaxoSmithKline, LLC. with $466.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 26 | $466 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $227 |
| Verona Pharma, Inc. VRNA | 3 | $86.94 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $84.68 |
| Genzyme Corporation SNY | 3 | $77.15 |
| Amgen Inc. AMGN | 3 | $74.33 |
| Mallinckrodt Hospital Products Inc. | 3 | $72.66 |
| Insmed, Inc. INSM | 3 | $67.97 |
| Axsome Therapeutics, Inc. AXSM | 2 | $56.24 |
| ZOLL Respicardia, Inc. | 1 | $56.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.